+8 Commodity PressureSite uses some generic platform language, but product reads as a specialized clinical workflow tool rather than an easily copyable AI widget.
Uses buzzwords like 'platform', 'integration', 'collaboration', and 'next-generation'Primary messaging emphasizes clinical planning and safety rather than lightweight AI features
+6 Model DependencyNo obvious dependence on third‑party foundation models today — AI is aspirational ("predictive digital twin") rather than core.
Roadmap mentions an aspiration to evolve into a 'predictive digital twin' and 'advanced simulations' (future implication)No explicit AI/ML product claims or model vendor mentions on the site
-18 Workflow OwnershipDesigned specifically for stereotactic planning (sEEG/LiTT/DBS) with documented real-world use — appears central to the clinical procedure workflow.
Described as 'designed for the planning of stereotactic procedures' and 'features tailored to optimize the sEEG pipeline'Documented use: 'used ... to assist in the planning of over 150 sEEG and 40 LiTT procedures'Emphasis on multidisciplinary and collaborative workflows and clinical product specialists
-4 Distribution EmbeddednessSome institutional traction and clinical partnerships, but no visible platform partnerships or embedded channels (EHR, device partners) listed.
Deployed in leading epilepsy surgery centers across Spain and references to Hospital del MarCollaborations with Hospital La Fe (Valencia) and Saint Louis Hospital (USA)Presence at major clinical congresses and research collaborations
-4 Integration DepthClaims a 'multimodal environment' and an 'Integration' pillar, but lacks named integrations or standards to prove deep technical entanglement.
Claims 'Unifying all imaging in one environment' and highlights a 'Multimodal environment'Pillar labeled 'Integration' but no specific APIs, vendors, or standards listed
-8 Enterprise TrustClear regulatory and quality focus plus hospital deployments signal real enterprise-level trust and procurement readiness.
Advancing through CE marking regulation and named PRRC (Person responsible for regulatory compliance)Quality & Regulatory Affairs roles on the team and company registration/contact details providedDeployed in hospital settings and involvement in clinical congresses
-12 Switching CostClinical deployments, procedure-specific features, and onboarding/support roles suggest meaningful switching friction for hospitals.
Documented live use in many procedures (150+ sEEG, 40 LiTT) implying data/practice habituationClinical product specialists on team indicating onboarding and operational support
-3 Monetization MaturityEarly commercial footprint with hospital deployments and research collaborations, but pricing is hidden and commercial scale is unclear.
Deployed in clinical centers and reference hospital partnerships existPricing not visible and product currently 'for investigational purposes' in places
+4 Category BaselineVertical workflow products start safer than generic assistants.
vertical workflow
-4 Relative PlacementModestly safer than scored — real clinical workflow ownership, regulatory traction, and switching friction justify a small downward adjustment versus generic vertical peers.
Documented real‑world use: 'used ... to assist in the planning of over 150 sEEG and 40 LiTT procedures' — strong workflow ownership and habituation.Regulatory and enterprise signals: advancing CE marking, named PRRC and Quality & Regulatory roles indicate procurement readiness and higher switching friction.Primary buyers are hospitals/clinical teams with multidisciplinary workflows, which are harder to displace than consumer or light B2B apps.